0001209191-16-128684.txt : 20160617 0001209191-16-128684.hdr.sgml : 20160617 20160617180556 ACCESSION NUMBER: 0001209191-16-128684 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160616 FILED AS OF DATE: 20160617 DATE AS OF CHANGE: 20160617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001347178 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030491827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 202-734-3400 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BATE KENNETH CENTRAL INDEX KEY: 0001210238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34186 FILM NUMBER: 161721044 MAIL ADDRESS: STREET 1: C/O MILLENNIUM PHARMACEUTICALS INC STREET 2: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-16 0 0001347178 Vanda Pharmaceuticals Inc. VNDA 0001210238 BATE KENNETH 2200 PENNSYLVANIA AVENUE SUITE 300 E WASHINGTON DC 20037 1 0 0 0 Stock Option (Right to Buy) 10.93 2016-06-16 4 A 0 15000 0.00 A 2026-06-15 Common Stock 15000 15000 D Option granted upon conclusion of annual meeting of stockholders pursuant to the provisions of the Issuer's outside director compensation program providing for annual option grants for outside directors. Exercisable in equal monthly installments over 12 months starting one month after the grant date, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date. /s/ Kenneth M. Bate 2016-06-17